Cargando…
Antenatal corticosteroid administration and attention-deficit/hyperactivity disorder in childhood: a regression discontinuity study
BACKGROUND: Antenatal corticosteroids reduce respiratory morbidity in preterm infants, but their use during late preterm gestation (34–36 weeks) is limited because their safety for longer-term child neurodevelopment is unclear. We sought to determine if fetuses with higher probability of exposure to...
Autores principales: | Hutcheon, Jennifer A., Strumpf, Erin C., Liauw, Jessica, Skoll, M. Amanda, Socha, Peter, Srour, Myriam, Ting, Joseph Y., Harper, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863198/ https://www.ncbi.nlm.nih.gov/pubmed/35193860 http://dx.doi.org/10.1503/cmaj.211491 |
Ejemplares similares
-
Antenatal corticosteroid administration and early school age child development: A regression discontinuity study in British Columbia, Canada
por: Hutcheon, Jennifer A., et al.
Publicado: (2020) -
Counterpoint: The value of benchmarking in observational studies of the longer term safety of antenatal corticosteroids
por: Hutcheon, Jennifer A., et al.
Publicado: (2022) -
Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020) -
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014) -
Understanding what patients and physicians need to improve their decision-making about antenatal corticosteroids in late preterm gestation: a qualitative framework analysis
por: Foggin, Hannah, et al.
Publicado: (2023)